ITSI seeks a Business Manager in Johnstown, PA, responsible for managing all of the financial aspects of ITSI-biosciences’ business, including preparing and maintaining all accounting and financial records to ensure accuracy and legal compliance as well as monitoring project costs, approving expenses, managing customer project accounts and ensuring timely payment collections. specific duties include: (i)… Read more »
Posts By: wp-admin
Most people have a working knowledge of genetics. Many of us learned about the basics of genetics and inherited traits back in middle school, but fail to remember the ins and outs of how it works. You might blame genetics for your crooked teeth or a bad back, but there are countless ways that genetic… Read more »
Noninvasive prenatal sampling, also known as noninvasive prenatal testing, can offer new parents a variety of benefits. This harmless test is performed by doctors and DNA testing services across the country in order to determine genetic abnormalities in the fetus. All the mother needs to do is offer a small sample of blood for DNA… Read more »
DNA profiling, formerly known as DNA fingerprinting, is a chemical test that aims at showing the genetic makeup of a person. The tests help in identifying a person and his or her kin. Nowadays, criminal agencies are using technology to identify criminals and solve crimes. The technology is also used for proving or disapproving specific… Read more »
ITSI Biosciences supports many laboratories, educational institutions, municipalities, and medical practices for a variety of purposes. Here are five examples of services ITSI Biosciences provides: Research Support Biomedical research has exploded over the past few decades and the number of jobs in the biomedical field is estimated to grow by over 20%. ITSI Biosciences supports… Read more »
DNA was first used as a forensic tool in the United States in 1988 but its roots can be traced back to the origination of biotechnology originated in 1919. But what is DNA analysis? DNA analysis, when used as a forensic tool, uses “short tandem repeat” (or STR) analysis. By counting the number of… Read more »
The roots of biotechnology go all the way back to 1919, but it has not stopped growing and changing as the years go on. In fact, it only took 50 years for researchers to perform the first successful experiment with recombinant DNA. The technology and knowledge available in this field continues to expand, even today…. Read more »
Biotechnology is a crucial part of modern medicine and science. The ability to perform tasks such as protein testing services and DNA testing services allows humans to learn more about themselves and the world around them. Identifying the presence of the Anti Smith antibody (anti-Sm antibody) can help to diagnose specific diseases. The use of… Read more »
What is DNA Testing? DNA Testing Services (also referred to as protein testing services) have been getting more and more attention lately. With large companies like Ancestry.com and 23andMe, it’s no wonder people are curious about DNA testing services. But just what can you learn? What is DNA analysis and how does it work? Let’s… Read more »
If you are a lab professional, you know that buying the right lab equipment can be a challenging task when you do not know the things to consider. You need to ensure that you have the right tool for your work. Your customers will be expecting accurate results after analysis of their samples, and this… Read more »
Human curiosity has pushed the pursuit of biomedical science incredibly far in recent years. That said, it’s nothing we haven’t been exploring for years. Biotechnology traces its roots back to 1919, but the burning question what is DNA analysis? was inaccessible for another 50 years until researchers performed the first successful recombinant DNA experiment. From then on,… Read more »
Testing is an important part of the medical field. It plays a crucial role in diagnostics. A total protein assay kit helps doctors analyze what is going on with their patients. Whether the doctor is conducting a routine health check, investigating unexplained weight loss or fatigue, or checking for kidney or liver disease, a protein test is… Read more »
You don’t have to suffer for your health. If you’re anything like most Americans, the fear of painful tests prevents you from getting the help you need. If you feel that taking tests at the doctor’s office has to be invasive, let us tell you about a great way to avoid this. One of the… Read more »
QuantiGene Plex is a powerful tool. The right QuantiGene service can aid drug discovery and development. It can be a great addition to your lab’s tools for clinical research. Notice we said the “right” QuantiGene service. How can you tell the difference between the best QuantiGene services and the ones you should avoid? That’s exactly… Read more »
The human body functions in amazing ways to keep foreign invaders from entering. Upon detection, immune cells act to neutralize and remove pathogens. They tag them as dangerous, endocytosis, phagocytosis, and pinocytosis. Blood proteins called antibodies essentially sniff out specific antigens, discerning between self and non-self particles. Then, they appropriately dispose of them. Unfortunately, the body gets mixed… Read more »
Proteins are one of four macromolecule building blocks that are necessary for any form of life. That’s why being able to analyze proteins with a protein assay is crucial in both research and diagnosis. Total protein assay kits can be used to determine the total protein concentration of a sample. To help you choose the… Read more »
ITSI-Biosciences, wins local Small Business Association Exporter of the Year Awards. Read full press release article
ProDM – A Colorimetric Kit for Rapid Monitoring and Standardization of Tryptic Digestion for Improved and Reproducible Shotgun Proteomics was presented at the US HUPO 9th Annual Conference March 10 – 13, 2013. See poster
FLASH™ XTN™ TALE Nuclease technology, discussed in GEN shows incredible promise in producing “…high-precision and high-efficiency modifications in a target gene sequence to produce basic research tools and to enable dramatically improved gene therapy.” -Anton Simeonov (NIH)
… 68 district winners, his nomination was forwarded to their respective regional office – in this case Region 3, which spans Delaware, Philadelphia, Pittsburgh, Maryland, Virginia, Washington, D.C., and West Virginia – where he became the regional winner. The breast cancer screening effort is funded by a grant from the National Institute of Health… Read more »
iTRAQ detects eEF1A1 as a candidate biomarker for Metastatic Progression of Prostate Cancer ITSI-Biosciences’ latest newsflash publication, “iTRAQ detects eEF1A1 as a candidate biomarker for Metastatic Progression of Prostate Cancer” discusses how PSA is plagued with controversies and is unreliable because of its potential to provide false positive and false negative results. Hence additional biomarkers… Read more »
ITSI-Biosciences has renewed its Blanket Purchase Agreement (BPA#: HHSN263200900168B) with the NIH Our products and services are customized for researchers interested in biomarker discovery/validation and protein expression monitoring using human and non-human models. We strive to deliver the best products and quality results to you on a timely basis and within your budget. We would… Read more »
Read full article
ITSI-Biosciences is pleased to announce that Concurrent Technologies and Services (CTS) and Biomax Co, LTD have been selected as the 2011 “Most Outstanding Distributor of the Year” and “Best New Distributor of the Year”, respectively. ITSI-Biosciences distributors’ award recognizes re-sellers of our products for their sales and marketing excellence and for working with ITSI-Biosciences to satisfy the needs of… Read more »
Johnstown, PA ITSI Biosciences is pleased to announce the introduction of a unique line of space-saving laboratory instruments ideal for laboratory and field use. This new line includes the ITSI Vortex Mixer and the ITSI Magnetic Stirrer for use in laboratories and field research. Both units operate with a small electrical (6V) adapter or batteries… Read more »
ITSI-Biosciences (www.itsibio.com) today announced that Cheryl Napier, M.S is the lucky winner of the Acer Net Book that was displayed at ITSI- Biosciences booth during the 2010 American Association for Cancer Research Annual Meeting in Washington D.C from April 17 – 21. Mr. James White, Economic Development Coordinator for the City of Johnstown, PA drew the lucky entry… Read more »
Johnstown, Pennsylvania, USA ITSI Bioscience a leading global proteomics, genomics and bioreagent solutions company located in Johnstown, PA has awarded Funakoshi Co., Ltd of Tokyo, Japan their prestigious Distributor of the Year Award for 2009. Criteria for the award included new sales volume, market penetration and customer satisfaction. This year’s award winner, Funakoshi Co., Ltd has… Read more »
ITSI Biosciences is pleased to announce the addition of Richard Cosgrove as Vice President of Operations and Business Development to the organization. Mr. Cosgrove will be directly responsible for all aspects of business development and marketing to help ITSI Biosciences expand its domestic and international market share in academic, corporate and government sectors, as well… Read more »
New lab, NCI funding provide ITSI-Biosciences with broader base for new breast-cancer detection test is featured in Keystone Edge.
ITSI-Biosciences and President and CSO Richard Somiari Ph.D. is prominently featured in the 11/24/05 issue of Nature.
Proteomics on Formalin-Fixed Parafin-Embedded Tissues ITSI-Biosciences’ latest newsflash publication, “Proteomics on Formalin-Fixed Parafin-Embedded Tissues” discusses how Formalin-Fixed Paraffin Embedded Tissues (FFPE) are commonly used in healthcare to preserve tissues from a wide variety and different stages of a disease. However formalin cross links the protein and poses a great obstacle for downstream proteomics application. Download… Read more »
ITSI-Biosciences’ latest application note, “ITSIPrep Kits for Two Dimensional Difference in Gel Electrophoresisâ€ discusses how to: 1) Achieve great results in 2D-DIGE experiments. 2) Streamline and standardize the up-stream sample preparation steps including protein isolation, fractionation, precipitation and depletion. 3) Avoid the use of poor quality reagents and inadequate protocols which results to poor quality… Read more »
ITSI-Biosciences wins Small Business Exporter of the Year, and is being awarded by The Saint Francis University Small Business Center, Friday June 17th, 2011. This award recognizes the outstanding achievements of the Southern Alleghenies Region’s most successful entrepreneurs and small business advocates.
ITSI-Biosciences featured in Commercial News USA, the official export magazine of the U.S. Department of Commerce. Commercial News USA is the premiere export promotion program for promoting U.S. goods and services in more than 178 countries around the world. The catalog-style magazine reaches more than a quarter million buyers and distributors worldwide. The magazine is… Read more »
Funakoshi Co., Ltd of Tokyo a leading distributor of bioreagents in Japan has been named the ITSI-Biosciences 2010 “Distributor of the Year”. This is the second time that Funakoshi is wining this distinguished and highly competitive award. Funakoshi Co., Ltd has continued to contribute to the growth of ITSI-Biosciences products in Japan. Criteria for selecting… Read more »
Mr. Koop toured the new state-of-the-art facility to learn more about ITSI’s business and operations in Johnstown. As Congressman Critz’s field representative Mr. Koop is helping ITSI-Biosciences establish strategic relationships, expand operations and take advantage of the unique opportunities for life science and biotechnology companies in the Johnstown area and 12th congressional district.
Two PhD Research Fellows from Olabisi Onabanjo University, Nigeria, arrived in Johnstown, PA today to commence research programing at ITSI – Biosciences. The two students will be in the United States for 6 months researching on Sickle Cells and Breast Cancer. Picture Legend from the left: Mutu A. Alabi (Phd Research Fellow in Breast Cancer),… Read more »
Chuck Witkowski founder of Protein Discovery visits ITSI-Biosciences facility today. Mr Witkowski is is a visionary leader with demonstrated expertise in building successful medical and life science companies from inception. Picture Legend from the left: Dr. Richard Somiari (President & Chief Scientific Officer of ITSI-Biosciences), Chuck Witkowski (President & Chief Scientific Officer)
“ITSI – Biosciences host summer interns”. Five students will be at ITSI – Biosciences for 7 weeks as interns. Three are high school graduates; Nicole Danchanko that will be going to Penn Highlands Community College in the fall to study Biology, Richard Somiari Jr going to Lehigh University also in the fall to study Computer… Read more »
ITSI, LLC today announced the commencement of the second phase of the training for the visiting Nigerian Defence Headquarters (DHQ) Knowledge Management System (KMS) project personnel in San Antonio, TX. This phase of the training is provided by BIF Technologies of San Antonio, TX. BIF is ITSI’s technical partner for implementation and management of the… Read more »
ITSIBIO today announced that ITSI Biosciences and Cybergenetics (www.cybgen.com) are collaborating to train the Nigerian Armed Forces DNA Bank (AFDB) personnel, and implement modern methods for forensic DNA analysis and interpretation in Nigeria. As part of this strategic relationship 6 AFDB personnel undergoing training at ITSI Biosciences since September 2009 have visited and trained at… Read more »
ITSIBIO has signed a representation and distribution agreement with 2B Scientific Limited, Upper Heyford, United Kingdom. 2B Scientific (www.2bscientific.com), a specialist reagents distribution company to the UK Life Science Markets will serve as a springboard for European markets. This appointment gives 2B Scientific the rights to promote, market, distribute and sell ITSIBIO products in Europe…. Read more »
ITSIBIO today announced that Nigerian Defence Headquarters Research and Development leaders, Major Gen BT Obasa (Chief, Research & Development) and Air Vice Marshall A Badeh (Director of Research) and Dr Richard I. Somiari (President & CSO) ITSI – Biosciences, LLC toured the Nigerian Armed Forces DNA Bank at Mogadishu Barracks, in Abuja, Nigeria. ITSI Biosciences… Read more »
ITSIBIO today announced that 6 Nigerian AFDB personnel visited the United States Department of Defense (DoD) Armed Forces DNA Identification Laboratory (AFDIL; www.afip.org/consultation/AFMES/AFDIL/index.html) in Rockville, MD and Armed Forces Repository of Specimen Samples for the Identification of Remains (AFRSSIR; www.afip.org/consultation/AFMES/AFDIL/AFRSSIR/) in Gaithersburg, MD. The visit is part of the comprehensive forensics DNA banking and analysis training organized… Read more »
ITSIBIO today announced that instructors from AFDIL based in Rockville, MD have arrived Johnstown, PA to help train Nigerian Armed Forces DNA Bank (AFDB) personnel. The AFDIL team led by Michael D. Coble, PhD (Research Section Chief) arrived in Johnstown, PA on the 8th of December 2009. According to Richard Somiari, PhD, President of ITSI,… Read more »
ITSI, LLC today announced the arrival of 6 Nigerian Defence Headquarters (DHQ) personnel in Johnstown, PA to commence five months computer science and knowledge management system training. According to Richard I Somiari, President and CEO of ITSI,Â the training is part of the MOU between DHQ and ITSI concerned with the design, construction and setting… Read more »
Mr. Cosgrove will be directly responsible for all aspects of business development and marketing to help ITSI Biosciences expand its domestic and international market share in academic, corporate and government sectors, as well as managing operations of the company’s business units. According to Richard Somiari, PhD, President and CEO, “We are extremely pleased to have… Read more »
Six members of the Nigerian Armed Forces DNA Bank (AFDB) representing the Army, Navy and Air force, arrived in Johnstown, PA today to commence DNA banking and analysis training at ITSI Biosciences. The team will be in the United States for 8 months learning new DNA banking and analysis methods. According to Richard Somiari, PhD,… Read more »
ITSIBIO today announced its movement into its new and larger facility. The new state-of-the-art facility in the Kernville district of Johnstown, PA is a green building with a silver status. The new facility includes more office space, expanded research laboratory and kit manufacturing space, and an ISO Certified Class 1000 clean room. This move is… Read more »
ITSIBIO today announced the introduction of a new and improved packaging for its distinctive line of ITSIPrep products. The new colorful and distinctive packaging is a marketing tool that reflects the key attributes of ITSIPrep line of products. This new packaging replaces the plain white package that the company has been using for three years…. Read more »
ITSI Bioscience has announced that it is a Subrecipient of a $2 million 5 year RO1 grant awarded to Dr Karam El-Bayoumy of Penn State University Cancer Center. This NCI subaward will fund proteomics research at ITSI Biosciences, focusing on the identification of biomarkers of prostate cancer risk. Specifically, ITSIBio will utilize high performance 2D-DIGE… Read more »
Dr. Richard Somiari, the founder of ITSI Biosciences, a life-science enterprise in the Johnstown region, is preparing to move his company into its new headquarters by year’s end–just in time to expand field investigations of a blood-sampling method that promises to increase the speed and lower the cost for early detection of breast cancer. That… Read more »
ITSI – Bioscience www.itsibio.com has announced the receipt of a $100,000 Small Business Innovation Research (SBIR) Phase 1 grant from the National Cancer Institute. The grant will support ITSIBIO’s ongoing blood-based breast cancer detection biomarker program that promises to provide an alternate method for earlier detection and accurate classification of breast malignancies. At the moment… Read more »
ITSIBIO has signed a representation and distribution agreement with Life Sciences-Ltda (http://www.life-sciences.com.br), Sao Paulo, Brazil. This agreement, which is effective from March 14th 2008, gives Life Sciences exclusive rights to promote, market and distribute ITSIBIO products in Brazil. Clients in this territory can now place orders for all products through Life Sciences.
ITSIBIO has signed a representation and distribution agreement with Precision Technologies PTE Ltd, Singapore (www.pretech.com.sg). This agreement, which is effective March 17th 2008, gives Precision Technologies exclusive rights to promote, market and distribute ITSIBIO products in Singapore, Malaysia and Indonesia. Clients in this territory can now place orders for all ITSIBIO products through Precision Technologies…. Read more »
The new ITSIBio facility is to be completed in August 2008.
NCI has extended the Blanket Purchase Agreement (BPA), originally signed with ITSIBIO in 2005, until 2010. This highly successful BPA which is managed by SAIC-Frederick, allows all NCI researchers to purchase genomics, proteomics and mass spectrometry services, and consumables from ITSIBIO at a pre-negotiated price. The BPA streamlines the process of outsourcing analytical support and… Read more »
ITSIBIO enters the Indian market by signing an exclusive agreement with SR Biosytem of New Delhi. Under the agreement signed May 2007, SR Biosytem will promote, market and distribute all ITSIBIO’s line of products, accessories and services in India. All orders in the Indian sub-continent should now be placed through SR Biosystem.
ITSI signs an exclusive agreement with Separation Scientific (SA) (PTY) Ltd, of South Africa. Under the agreement that is effective from April 2007, Separation Scientific will promote, market and distribute all ITSIBIO’s products and services in the South Africa and other neighboring countries. Clients in Southern Africa should now place orders through Separation Scientific (SA) (PTY).
Pennsylvania Governor Rendell announces the investment of $500,000 to enable ITSI to expand its research facility and operations.
ITSI representative invited to speak at the South African Bio2Biz International Biotechnology Conference, Durban, South Africa. A paper titled From Genomics and Proteomics to Bio-Business presented.
ITSI representative invited to speak at the International Symposium on Inflammation: An Underlying Factor in Several Diseases, Ibadan, Nigeria. A paper titled Role of Proteomics in Inflammation Research presented as a keynote lecture.
ITSI signs a collaboration agreement with the Advancement Center, College of Medicine, University of Nigeria. Under this agreement ITSI will work with the College of Medicine to develop integrated biomedical research programs and a biorepository to support cancer and complex disease research.
ITSI signs an exclusive Representative and Distributorship agreement with InterSciences Inc., Markham Ontario, Canada. Under this agreement, InterSciences will promote, market and distribute the ITSIPREP™ line of products and easy-to-use kits for protein isolation, protein fractionation, protein precipitation, albumin removal and protein assay in Canada.
Dr Munir O. Azeez (Col.) of the Nigerian Army Medical Corps (NAMC) joins ITSI for six months advanced biomedical research training, as part of the training and collaboration agreement between ITSI and NAMC. Dr Azeez is interested in applying advanced proteomic technologies to study tissue from patients diagnosed with temporo-mandibular joint disease.
ITSI signs an exclusive distribution agreement with Funakoshi Japan. Funakoshi will promote, market and sell the ITSIPREP™ line of products in Japan. www.funakoshi.co.jp
ITSI signs a non-exclusive Sales Representative Agreement with Grace Scientific LLC, Clarksburg, MD, USA. Grace Scientific will promote, market and sell ITSI’s services, especially 2D-DIGE and 2D-Image analysis services and all the ITSIPREP™ line of products in the Maryland, Washington DC and Virginia area.
ITSI signs an exclusive Representative and Distributorship agreement with Rainbow Biotechnology Co., Taipei, Taiwan. Rainbow will promote, market and distribute the ITSIPREP™ line of products including optimized and easy-to-use kits for protein isolation, protein fractionation, protein precipitation, albumin removal and protein assay. www.rainbowbiotech.com.tw
Itsi-Biosciences has moved to a new, larger location. Images of our new facility and additional information will available online shortly. Please see the Contact page for our new address.
ITSI appoints Syngenic Biotecnologia Ltda., Sao Paolo Brazil as the exclusive distributor of the ITSIPREP™ line of products in Brazil. The agreement, which was signed in October 2005, covers all the optimized and easy-to-use kits for protein isolation, protein fractionation, protein precipitation, albumin removal and protein assay.
ITSI-Biosciences President and CSO Richard Somiari Ph.D. is prominently featured in the 11/24/05 issue of Nature.
Itsibio represented at GE Healthcare 2D-DIGE Users Group meeting in Nashville, TN. Presents paper “Application of 2D-DIGE technology for the analysis of clinical specimens.”
Robin L. Fisher, Director Asia & Europe, International Business Development, PA DCED, Mr. Donald M. Bonk, International Trade Manager, SAPDC and Ms. Sushama A Kanetkar, Director, PA Trade Representative Office in India, and Supriya, Trade & Investment Advisor, PA Trade Office India visit Itsibio corporate headquarters/laboratory to discuss export opportunities and entry into the Indian market.
ITSIBIO invited to exhibit products at the Cambria County Chamber of Commerce Small Business Expo in Ebensburg, PA
Itsibio and Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil sign agreement to explore business opportunities of mutual interest involving proteomics, clinical research/trials, tissue repository development and management. ITSIBIO representative met with Prof. Carlos Menke and staff of Hospital de Clinicas de Porto Alegre in Porto Alegre, Brazil on the… Read more »
Itsibio, Applied Isotope Technologies and MountainTop Technologies sign agreement to explore business opportunities of mutual interest involving proteomics.
Itsibio and Lampire Biological Laboratories, Pipersville, PA sign a three year collaboration and teaming agreement covering antibody production, bioreagent development and proteomics.
Itsibio signs a distribution agreement with Biomedical Marketing Associates. BMA will market and distribute ITSI’s proteomics products including protein isolation, fractionation and assay kits in 5 states: Michigan, Ohio, Kentucky, West Virginia and Western Pennsylvania.
David H. Fyock, Chairman/CEO, MountainTop Technologies Inc., Matt Pamuku, President, Applied Isotope Technologies, Inc., Prof. HM (Skip) Kingston, PhD, Duquesne University and Dr. Steve Ayanruoh, MD, Chairman, Ruskat Medical Equipment Corp and Applied Medical Technologies, visit Itsibio to discuss collaboration and teaming agreement.
Stephen C. Metzger, Director Business Lending Services of Southern Allegheny Planning & Development Commission, Altoona, PA visits itsibio to discuss funding opportunities and support. SAPDC is supporting itsibio’s effort to export bioanalytical reagents produced in Johnstown, PA to Mexico and Brazil, and to access funds through the Small Business First loan program.
D. Brian Krier (Director Business Development) and Sherry A. Davidson (Account Manager) both of The Ben Franklin Transformation Services Network, Altoona/University Park, PA visit Itsibio. Ben Franklin Technology Partners has been helping Itsibio since June of 2005 to strategize and transform our overall operations to become more efficient and competitive, both nationally and globally.
Ed Huttenhower, Director, Small Business Development Center (SBDC)/Center for Global Competitiveness, St Francis University, Loretto, PA visits Itsibio. SBDC is helping Itsibio enter foreign markets, prepare targeted marketing materials and screen foreign companies interested in distribution of Itsibio’s protein isolation and protein assay kits in Mexico and Brazil.
Prof. Francis A.A. Adeniyi, Dean, Faculty of Basic Medical Sciences and Ag. Director, Institute for Advanced Medical Research & Training (IMRAT), University of Ibadan, Ibadan, Nigeria visits itsi-Biosciences to discuss collaboration in the areas of biomedical research, bioanalytical support, tissue banking and data center development.
Itsibio acquires ProteinChip System Series 4000 Enterprise Edition Surface Enhanced Laser Desorbed Ionization – Time of Flight (SELDI-Tof) fromCiphergen Biosystems as part of an emerging collaboration between Itsibio and Ciphergen. The system, which is the best for analysis of serum, plasma, urine and saliva will support internal biomarker discovery programs and will enable Itsibio to provide contract biomarker… Read more »
Itsibio representatives visit NCI-Frederick, Frederick MD. Present seminar “Integrating emerging high throughput technologies for complex disease research”
Itsibio representatives visit GE Healthcare, Piscataway NJ. Meet with Andy Bertera, Head of Marketing, Gene & Protein Discovery.
Itsibio attends Bio 2005, meets with potential partners from around the world.
Itsibio representative visits Hospital das Clinicas de Porto Alegre, Universidade Federal do Rio Grande Sul, Porto Alegre, Brazil. Presents seminar “Advances in Tissue Banking & Biomedical Research” and meets with Prof Dr. Carlos Menke and top faculty members to discuss partnership.
Mr. Joseph Burke, Director, Americas, So. Africa, Mid. East & Oceania Grp., PA DCED, Mr. Donald M. Bonk, International Trade Manager, SAPDC and Ms. Silvia Alonso, Senior Trade Specialist for PA in Mexico visit itsibio corporate headquarters/laboratory.
Itsibio attends American Society of Breast Disease (ASBD) annual meeting (April 13-16 2005) in Las Vegas, NV. Itsibio representative serves on the Outreach and special populations committee and is a member of the Expert working group on risk assessment of the ASBD.
Itsibio representative visits University of Nigeria, Nsukka, Nigeria and presents seminar “Emerging high throughput technologies and complex disease research” Meets with Director, University Resource Foundation, Provost, University of Nigeria Teaching Hospital, Chief Medical Director, University of Nigeria Teaching Hospital and other senior faculty and university administrators to discuss partnership between both organizations.
Itsibio representative visits the Institute of Advanced Medical Research & Training, University of Ibadan, Nigeria and University College Hospital, Ibadan, Nigeria. Presents a seminar &;Advances in High throughput Biomedical Research & Personalized Medicine. Meets with Prof E. Bababunmi, Prof. Francis AA Adeniyi and Prof. Idowu Yinka and other senior faculty members to discuss partnership between both… Read more »
Itsibio representative attends the launching of the Nigerian Army Medical Corps/School (NAMC/S) rollback malaria program. Meets with the Honorable Minister of State for defense Dr. Roland Oritsejafor, Lt. Gen ML Agwai (Chief of Army Staff) and Maj. Gen B. E. Abang (Commandant NAMC/S).
Itsibio representative visits and presents a seminar; Application of emerging high throughput technologies in complex disease research; at the College of Pharmacy, University of Houston, TX. Meets with Dean Sunny Ohia and senior faculty.
Itsibio and Asterand Inc. sign collaboration agreement.
Itsibio formally opens ultra-modern laboratory for genomics and proteomics research and provision of bioanalytical services.